Alex Pellerin
Pre-Doctoral Trainee (previously held)
Boston University School of Medicine, Graduate Medical Sciences
Dept of Program in Biomedical Sciences





Alex Pellerin is a former pre-doctoral trainee at BUSM and current scientist at Biogen in Cambridge.

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl CA, Zhu J, Jandreski L, Cullen P, Carlile TM, Li A, Rebollar JV, Sybulski J, Reynolds TL, Zhang B, Basile R, Tang H, Harp CP, Pellerin A, Silbereis J, Franchimont N, Cahir-McFarland E, Ransohoff RM, Cameron TO, Mingueneau M. MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain. 2021 Sep 04; 144(8):2361-2374. PMID: 34145876
     
  2. Pellerin A, Yasuda K, Cohen-Bucay A, Sandra V, Shukla P, Jr BKH, Nündel K, Viglianti GA, Xie Y, Klein U, Tan Y, Bonegio RG, Rifkin IR. Monoallelic IRF5 deficiency in B cells prevents murine lupus. JCI Insight. 2021 Aug 09; 6(15).View Related Profiles. PMID: 34197340; PMCID: PMC8410043; DOI: 10.1172/jci.insight.141395;
     
  3. Bame E, Tang H, Burns JC, Arefayene M, Michelsen K, Ma B, Marx I, Prince R, Roach AM, Poreci U, Donaldson D, Cullen P, Casey F, Zhu J, Carlile TM, Sangurdekar D, Zhang B, Trapa P, Santoro J, Muragan P, Pellerin A, Rubino S, Gianni D, Bajrami B, Peng X, Coppell A, Riester K, Belachew S, Mehta D, Palte M, Hopkins BT, Scaramozza M, Franchimont N, Mingueneau M. Next-generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clin Transl Immunology. 2021; 10(6):e1295. PMID: 34141433; PMCID: PMC8204096; DOI: 10.1002/cti2.1295;
     
  4. Gardet A, Pellerin A, McCarl CA, Diwanji R, Wang W, Donaldson D, Franchimont N, Werth VP, Rabah D. Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNa Production From Patients Affected With Cutaneous Lupus Erythematosus. Front Immunol. 2019; 10:275. PMID: 30846987; PMCID: PMC6394354; DOI: 10.3389/fimmu.2019.00275;
     
  5. Furie R, Werth VP, Merola JF, Stevenson L, Reynolds TL, Naik H, Wang W, Christmann R, Gardet A, Pellerin A, Hamann S, Auluck P, Barbey C, Gulati P, Rabah D, Franchimont N. Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus. J Clin Invest. 2019 03 01; 129(3):1359-1371. PMID: 30645203; PMCID: PMC6391094; DOI: 10.1172/JCI124466;
     
  6. Biliouris K, Nestorov I, Naik H, Dai D, Xiao G, Wang Q, Pellerin A, Rabah D, Lesko LJ, Trame MN. A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans. J Pharmacokinet Pharmacodyn. 2018 12; 45(6):817-827. PMID: 30377889
     
  7. Ding J, Zhang W, Haskett S, Pellerin A, Xu S, Petersen B, Jandreski L, Hamann S, Reynolds TL, Zheng TS, Mingueneau M. BAFF overexpression increases lymphocytic infiltration in Sjögren's target tissue, but only inefficiently promotes ectopic B-cell differentiation. Clin Immunol. 2016 08; 169:69-79. PMID: 27352977; DOI: 10.1016/j.clim.2016.06.007;
     
  8. Huss DJ, Pellerin AF, Collette BP, Kannan AK, Peng L, Datta A, Wipke BT, Fontenot JD. Anti-CD25 monoclonal antibody Fc variants differentially impact regulatory T cells and immune homeostasis. Immunology. 2016 Jul; 148(3):276-86. PMID: 27012310; PMCID: PMC4913290; DOI: 10.1111/imm.12609;
     
  9. Pellerin A, Otero K, Czerkowicz JM, Kerns HM, Shapiro RI, Ranger AM, Otipoby KL, Taylor FR, Cameron TO, Viney JL, Rabah D. Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms. EMBO Mol Med. 2015 Mar 11; 7(4):464-76. PMID: 25762615; PMCID: PMC4403047; DOI: 10.15252/emmm.201404719;
     
  10. Carlson TJ, Pellerin A, Djuretic IM, Trivigno C, Koralov SB, Rao A, Sundrud MS. Halofuginone-induced amino acid starvation regulates Stat3-dependent Th17 effector function and reduces established autoimmune inflammation. J Immunol. 2014 Mar 1; 192(5):2167-76. PMID: 24489094; PMCID: PMC3936195; DOI: 10.4049/jimmunol.1302316;
     
Showing 10 of 11 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 11 publications over 7 distinct years, with a maximum of 3 publications in 2021

YearPublications
20121
20141
20151
20162
20181
20192
20213

Contact for Mentoring:

Pellerin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department